Trial Profile
Clinical evaluation of BRL29060 A [paroxetine] in generalized anxiety disorder.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Aug 2023
Price :
$35
*
At a glance
- Drugs Paroxetine (Primary)
- Indications Generalised anxiety disorder
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline; GSK
- 29 Jan 2009 Actual patient numbers (361) added as reported by ClinicalTrials.gov.
- 29 Jan 2009 Actual end date (May 2006) added as reported by ClinicalTrials.gov.
- 29 Jan 2009 Actual initiation date changed from Feb 2003 to May 2006 as reported by ClinicalTrials.gov.